These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32415933)

  • 1. Effects of dexmedetomidine pretreatment on rats with sepsis-induced acute kidney injury and miR-146a expression.
    Ni J; He J; Kang L; Zhong Z; Wang L; Yin S
    Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):93-98. PubMed ID: 32415933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pretreatment with dexmedetomidine ameliorates renal inflammation and oxidative stress in rats with lipopolysaccharide-induced sepsis and acute kidney injury].
    Chen YJ; Gong CL; Tan F; Zhou SL
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Oct; 35(10):1472-5. PubMed ID: 26547344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil elastase in dexmedetomidine alleviating sepsis-related renal injury in rats.
    Chen L; Li M; Lin Y; Li Y; Liang M; Zeng K
    Int Immunopharmacol; 2023 Sep; 122():110441. PubMed ID: 37393835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dexmedetomidine on kidney injury in sepsis rats through TLR4/MyD88/NF-κB/iNOS signaling pathway.
    Jin YH; Li ZT; Chen H; Jiang XQ; Zhang YY; Wu F
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):5020-5025. PubMed ID: 31210339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexmedetomidine ameliorates lipopolysaccharide-induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK-3β/Nrf2 signaling pathway.
    Feng X; Guan W; Zhao Y; Wang C; Song M; Yao Y; Yang T; Fan H
    J Cell Physiol; 2019 Aug; 234(10):18994-19009. PubMed ID: 30919976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of 6-hydroxy-1-methylindole-3-acetonitrile on cisplatin-induced oxidative nephrotoxicity via Nrf2 inactivation.
    Moon JH; Shin JS; Kim JB; Baek NI; Cho YW; Lee YS; Kay HY; Kim SD; Lee KT
    Food Chem Toxicol; 2013 Dec; 62():159-66. PubMed ID: 23989062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine Attenuates Hypoxia/Reoxygenation Injury of H9C2 Myocardial Cells by Upregulating miR-146a Expression via the MAPK Signal Pathway.
    Chu Y; Teng J; Feng P; Liu H; Wang F; Wang H
    Pharmacology; 2022; 107(1-2):14-27. PubMed ID: 34718238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine attenuates ferroptosis by Keap1-Nrf2/HO-1 pathway in LPS-induced acute kidney injury.
    Luo RR; Yang J; Sun YL; Zhou BY; Zhou SX; Zhang GX; Yang AX
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Oct; 397(10):7785-7796. PubMed ID: 38722344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DMF attenuates cisplatin-induced kidney injury via activating Nrf2 signaling pathway and inhibiting NF-kB signaling pathway.
    Zhao K; Wen LB
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8924-8931. PubMed ID: 30575936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine Alleviates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting p75NTR-Mediated Oxidative Stress and Apoptosis.
    Wang Z; Wu J; Hu Z; Luo C; Wang P; Zhang Y; Li H
    Oxid Med Cell Longev; 2020; 2020():5454210. PubMed ID: 33194004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA GAS5 inhibits miR-579-3p to activate SIRT1/PGC-1α/Nrf2 signaling pathway to reduce cell pyroptosis in sepsis-associated renal injury.
    Ling H; Li Q; Duan ZP; Wang YJ; Hu BQ; Dai XG
    Am J Physiol Cell Physiol; 2021 Jul; 321(1):C117-C133. PubMed ID: 34010066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil gelatinase-associated lipocalin attenuates injury in the rat cecal ligation and puncture model of sepsis via apoptosis inhibition.
    Zhao S; Wei Y; Xu D
    Nephrology (Carlton); 2015 Sep; 20(9):646-53. PubMed ID: 25943501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dexmedetomidine on postoperative cognitive function of sleep deprivation rats based on changes in inflammatory response.
    Guo B; Chen C; Yang L; Zhu R
    Bioengineered; 2021 Dec; 12(1):7920-7928. PubMed ID: 34622713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal Stem Cells Modified with Heme Oxygenase-1 Have Enhanced Paracrine Function and Attenuate Lipopolysaccharide-Induced Inflammatory and Oxidative Damage in Pulmonary Microvascular Endothelial Cells.
    Chen X; Zhang Y; Wang W; Liu Z; Meng J; Han Z
    Cell Physiol Biochem; 2018; 49(1):101-122. PubMed ID: 30153667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine Attenuates Total Body Radiation-Induced Acute Liver Injury in Mice Through the Nrf2/HO-1 Pathway.
    Zhang C; Ren L; Zou M; Xu W; Zhang W; Liu G; Zhu B; Xu H; Meng X; Li X; Ji F
    Clin Lab; 2022 Aug; 68(8):. PubMed ID: 35975484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway.
    Zhao Y; Kong GY; Pei WM; Zhou B; Zhang QQ; Pan BB
    Eur Cytokine Netw; 2019 Sep; 30(3):88-97. PubMed ID: 31957703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4/NOX4/NF-κB pathway.
    Yao Y; Hu X; Feng X; Zhao Y; Song M; Wang C; Fan H
    J Cell Biochem; 2019 Oct; 120(10):18509-18523. PubMed ID: 31243816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine affects the NOX4/Nrf2 pathway to improve renal antioxidant capacity.
    Yang H; Chen Y; Wang Z; Huang Y; Ma Z; Zou Y; Dong J; Zhang H; Huo M; Lv M; Liu X; Zhang G; Wang S; Yang K; Zhong P; Jiang B; Kou Y; Chen Z
    J Pharm Pharmacol; 2024 Jul; 76(7):851-860. PubMed ID: 38625054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexmedetomidine attenuates acute stress-induced liver injury in rats by regulating the miR-34a-5p/ROS/JNK/p38 signaling pathway.
    Li D; Qian J; Li J; Wang J; Liu W; Li Q; Wu D
    J Toxicol Sci; 2022; 47(5):169-181. PubMed ID: 35527005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine inhibits inflammatory response and oxidative stress through regulating miR-205-5p by targeting HMGB1 in cerebral ischemic/reperfusion.
    Yang JJ; Zhao YH; Yin KW; Zhang XQ; Liu J
    Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):478-486. PubMed ID: 34196265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.